Inics Acquisition Boosts SK Bioscience's Flu and Ebola Vaccine Business [Stars IR]
Predicted impact: Low
Commentary on an earlier acquisition's benefits to vaccine business; no new deal size or figures given.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.